Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Tanzisertib

Catalog No. T14895Cas No. 899805-25-5
Alias CC-930

Tanzisertib (CC-930) (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.

Tanzisertib

Tanzisertib

Purity: 99.28%
Catalog No. T14895Alias CC-930Cas No. 899805-25-5
Tanzisertib (CC-930) (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.
Pack SizePriceAvailabilityQuantity
1 mg$35In Stock
5 mg$89In Stock
10 mg$148In Stock
25 mg$297In Stock
50 mg$588In Stock
100 mg$783In Stock
200 mg$1,080In Stock
1 mL x 10 mM (in DMSO)$88In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Tanzisertib"

Select Batch
Purity:99.28%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Tanzisertib (CC-930) (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.
Targets&IC50
JNK3:6 nM, JNK1:61 nM, JNK2:7 nM
In vitro
Tanzisertib (CC-930) inhibits the formation of phospho-cJun in human PBMC stimulated by phorbol-12-myristate-13-acetate and phytohemeagglutinin (IC50=1 μM)[1] and blocks the JNK pathway activated by pro-fibrotic cytokines in systemic sclerosis[3]. Tanzisertib (CC-930) (1-2 μM) substantially reduces and abrogates apoptosis and necrosis in hepatocytes, including FC-loaded WT hepatocytes[2].
In vivo
Tanzisertib (CC-930), when administered orally at doses of 10 and 30 mg/kg, decreases TNFa production by 23% and 77% respectively in the acute rat LPS-induced TNFa production PK-PD model[1]. Additionally, at a dose of 150 mg/kg, Tanzisertib (CC-930) not only prevents the development of fibrosis across various models but also reverses pre-existing fibrosis[3].
AliasCC-930
Chemical Properties
Molecular Weight448.44
FormulaC21H23F3N6O2
Cas No.899805-25-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 33 mg/mL (73.59 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2300 mL11.1498 mL22.2995 mL111.4976 mL
5 mM0.4460 mL2.2300 mL4.4599 mL22.2995 mL
10 mM0.2230 mL1.1150 mL2.2300 mL11.1498 mL
20 mM0.1115 mL0.5575 mL1.1150 mL5.5749 mL
50 mM0.0446 mL0.2230 mL0.4460 mL2.2300 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tanzisertib | purchase Tanzisertib | Tanzisertib cost | order Tanzisertib | Tanzisertib chemical structure | Tanzisertib in vivo | Tanzisertib in vitro | Tanzisertib formula | Tanzisertib molecular weight